Business
Bell Potter just upgraded the target price on ASX healthcare stock
Image source: Getty Images
Broker Bell Potter has issued a new report on ASX healthcare stock Neuren Pharmaceuticals Ltd (ASX: NEU).
It has maintained its buy rating and also increased its target price.
Neuren Pharmaceuticals is a biopharmaceutical company specialising in developing new…
Continue Reading